157 related articles for article (PubMed ID: 12544837)
21. Immunological memory to hyperphosphorylated tau in asymptomatic individuals.
Pascual G; Wadia JS; Zhu X; Keogh E; Kükrer B; van Ameijde J; Inganäs H; Siregar B; Perdok G; Diefenbach O; Nahar T; Sprengers I; Koldijk MH; der Linden EC; Peferoen LA; Zhang H; Yu W; Li X; Wagner M; Moreno V; Kim J; Costa M; West K; Fulton Z; Chammas L; Luckashenak N; Fletcher L; Holland T; Arnold C; Anthony Williamson R; Hoozemans JJ; Apetri A; Bard F; Wilson IA; Koudstaal W; Goudsmit J
Acta Neuropathol; 2017 May; 133(5):767-783. PubMed ID: 28341999
[TBL] [Abstract][Full Text] [Related]
22. Immunological characterization of epitopes on tau of Alzheimer's type and chemically modified tau.
Farías G; González-Billault C; Maccioni RB
Mol Cell Biochem; 1997 Mar; 168(1-2):59-66. PubMed ID: 9062894
[TBL] [Abstract][Full Text] [Related]
23. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau.
Schmidt ML; Huang R; Martin JA; Henley J; Mawal-Dewan M; Hurtig HI; Lee VM; Trojanowski JQ
J Neuropathol Exp Neurol; 1996 May; 55(5):534-9. PubMed ID: 8627344
[TBL] [Abstract][Full Text] [Related]
24. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein.
Goedert M; Jakes R; Crowther RA; Cohen P; Vanmechelen E; Vandermeeren M; Cras P
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):871-7. PubMed ID: 7519852
[TBL] [Abstract][Full Text] [Related]
25. The reinterpretation of the immunochemical study of Alzheimer neurofibrillary tangles.
Nukina N
Ann Med; 1989; 21(2):117-9. PubMed ID: 2475148
[TBL] [Abstract][Full Text] [Related]
26. [Human tau N-terminal domain-specific monoclonal antibodies: screening and application in blood detection].
Yan Z; Zhang Y; Jiang J; Liu Z; Wang H; Zhang Y; He J; Hong T
Sheng Wu Gong Cheng Xue Bao; 2024 May; 40(5):1571-1583. PubMed ID: 38783817
[TBL] [Abstract][Full Text] [Related]
27. Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics.
Rosseels J; Van den Brande J; Violet M; Jacobs D; Grognet P; Lopez J; Huvent I; Caldara M; Swinnen E; Papegaey A; Caillierez R; Buée-Scherrer V; Engelborghs S; Lippens G; Colin M; Buée L; Galas MC; Vanmechelen E; Winderickx J
J Biol Chem; 2015 Feb; 290(7):4059-74. PubMed ID: 25540200
[TBL] [Abstract][Full Text] [Related]
28. First insert of tau protein is present in all stages of tau pathology in Alzheimer's disease.
Soltys K; Rolkova G; Vechterova L; Filipcik P; Zilka N; Kontsekova E; Novak M
Neuroreport; 2005 Oct; 16(15):1677-81. PubMed ID: 16189476
[TBL] [Abstract][Full Text] [Related]
29. Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau.
Strang KH; Goodwin MS; Riffe C; Moore BD; Chakrabarty P; Levites Y; Golde TE; Giasson BI
Acta Neuropathol Commun; 2017 Jul; 5(1):58. PubMed ID: 28760159
[TBL] [Abstract][Full Text] [Related]
30. Characterization of TauC3 antibody and demonstration of its potential to block tau propagation.
Nicholls SB; DeVos SL; Commins C; Nobuhara C; Bennett RE; Corjuc DL; Maury E; Eftekharzadeh B; Akingbade O; Fan Z; Roe AD; Takeda S; Wegmann S; Hyman BT
PLoS One; 2017; 12(5):e0177914. PubMed ID: 28531180
[TBL] [Abstract][Full Text] [Related]
31. Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location.
Szendrei GI; Lee VM; Otvos L
J Neurosci Res; 1993 Feb; 34(2):243-9. PubMed ID: 7680727
[TBL] [Abstract][Full Text] [Related]
32. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
[TBL] [Abstract][Full Text] [Related]
33. Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease.
Endoh R; Ogawara M; Iwatsubo T; Nakano I; Mori H
Brain Res; 1993 Jan; 601(1-2):164-72. PubMed ID: 8431763
[TBL] [Abstract][Full Text] [Related]
34. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites.
Su JH; Cummings BJ; Cotman CW
Neuroreport; 1994 Nov; 5(17):2358-62. PubMed ID: 7533559
[TBL] [Abstract][Full Text] [Related]
35. Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro.
Nobuhara CK; DeVos SL; Commins C; Wegmann S; Moore BD; Roe AD; Costantino I; Frosch MP; Pitstick R; Carlson GA; Hock C; Nitsch RM; Montrasio F; Grimm J; Cheung AE; Dunah AW; Wittmann M; Bussiere T; Weinreb PH; Hyman BT; Takeda S
Am J Pathol; 2017 Jun; 187(6):1399-1412. PubMed ID: 28408124
[TBL] [Abstract][Full Text] [Related]
36. Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein.
Porzig R; Singer D; Hoffmann R
Biochem Biophys Res Commun; 2007 Jun; 358(2):644-9. PubMed ID: 17499212
[TBL] [Abstract][Full Text] [Related]
37. Early but not late conformational changes of tau in association with ubiquitination of neurofibrillary pathology in Alzheimer's disease brains.
Ibarra-Bracamontes VJ; Escobar-Herrera J; Kristofikova Z; Rípova D; Florán-Garduño B; Garcia-Sierra F
Brain Res; 2020 Oct; 1744():146953. PubMed ID: 32526294
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes.
Mercken M; Vandermeeren M; Lübke U; Six J; Boons J; Van de Voorde A; Martin JJ; Gheuens J
Acta Neuropathol; 1992; 84(3):265-72. PubMed ID: 1384266
[TBL] [Abstract][Full Text] [Related]
39. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
Gómez-Ramos P; Morán MA
Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
[TBL] [Abstract][Full Text] [Related]
40. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.
Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM
J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
